查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418355

奈米抗体市场报告：2030 年趋势、预测与竞争分析

Nanobody Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

奈米抗体趋势和预测

到 2030 年，全球奈米抗体市场预计将达到 28 亿美元，2024 年至 2030 年复合年增长率为 24.7%。该市场的主要驱动力是人们对精准医疗的兴趣日益浓厚以及对奈米抗体研发的支持不断增加。全球奈米抗体市场的未来充满希望，在治疗、诊断和研究市场中充满机会。

奈米抗体市场洞察

Lucintel 预测，由于不同癌症类型的存在不断增加，特异性奈米抗体预计将在预测期内出现强劲增长。

在这个市场中，由于製药公司越来越多地采用奈米抗体，研究仍然是最大的部分。

由于对奈米抗体技术的高度认识，北美在预测期内仍然是最大的地区。

常问问题

Q1.市场规模有多大？

A1. 到 2030 年，全球奈米抗体市场预计将达到 28 亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球奈米抗体市场预计将以24.7%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动因素是人们对精准医疗的兴趣日益浓厚以及对奈米抗体研发的支持不断增加。

Q4.市场的主要细分市场是什么？

A4. 奈米抗体市场的未来是充满希望的，在治疗、诊断和研究市场上都有机会。

Q5. 市场上主要企业有哪些？

A5. 主要奈米抗体公司如下。

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于各种癌症的增加，特异性奈米抗体将在预测期内出现强劲增长。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于对奈米抗体技术的高度认识，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球奈米抗体市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球奈米抗体市场趋势（2018-2023）与预测（2024-2030）
  • 按类型
    • 单一特异性
    • 多么具体的
  • 按用途
    • 治疗性的
    • 诊断
    • 调查
  • 按最终用途
    • 製药和生物技术公司
    • 调查
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的奈米抗体市场
  • 北美洲奈米抗体市场
  • 欧洲奈米抗体市场
  • 亚太奈米抗体市场
  • 其他地区奈米抗体市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球奈米抗体市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球奈米抗体市场容量
    • 全球奈米抗体市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical
简介目录

Nanobody Trends and Forecast

The future of the global nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets. The global nanobody market is expected to reach an estimated $2.8 billion by 2030 with a CAGR of 24.7% from 2024 to 2030. The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

A more than 150-page report is developed to help in your business decisions.

Nanobody by Segment

The study includes a forecast for the global nanobody by type, application, end use, and region.

Nanobody Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mono-Specific
  • Multi-Specific

Nanobody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic
  • Diagnostic
  • Research

Nanobody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
  • Others

Nanobody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Nanobody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nanobody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nanobody companies profiled in this report include-

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Nanobody Market Insights

Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Within this market, research will remain the largest segment due to growing adoption of nanobodies by pharmaceutical companies.

North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Features of the Global Nanobody Market

Market Size Estimates: Nanobody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nanobody market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Nanobody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the nanobody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nanobody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the nanobody market size?

Answer: The global nanobody market is expected to reach an estimated $2.8 billion by 2030.

Q2. What is the growth forecast for nanobody market?

Answer: The global nanobody market is expected to grow with a CAGR of 24.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the nanobody market?

Answer: The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

Q4. What are the major segments for nanobody market?

Answer: The future of the nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets.

Q5. Who are the key nanobody market companies?

Answer: Some of the key nanobody companies are as follows.

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Q6. Which nanobody market segment will be the largest in future?

Answer: Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Q7. In nanobody market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nanobody market by type (mono-specific and multi-specific), application (therapeutic, diagnostic, and research), end use (pharmaceutical & biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nanobody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Nanobody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Nanobody Market by Type
    • 3.3.1: Mono-Specific
    • 3.3.2: Multi-Specific
  • 3.4: Global Nanobody Market by Application
    • 3.4.1: Therapeutic
    • 3.4.2: Diagnostic
    • 3.4.3: Research
  • 3.5: Global Nanobody Market by End Use
    • 3.5.1: Pharmaceutical & Biotechnology Companies
    • 3.5.2: Research Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Nanobody Market by Region
  • 4.2: North American Nanobody Market
    • 4.2.2: North American Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.3: European Nanobody Market
    • 4.3.1: European Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.3.2: European Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.4: APAC Nanobody Market
    • 4.4.1: APAC Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.4.2: APAC Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.5: ROW Nanobody Market
    • 4.5.1: ROW Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.5.2: ROW Nanobody Market by Application: Therapeutic, Diagnostic, and Research

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nanobody Market by Type
    • 6.1.2: Growth Opportunities for the Global Nanobody Market by Application
    • 6.1.3: Growth Opportunities for the Global Nanobody Market by End Use
    • 6.1.4: Growth Opportunities for the Global Nanobody Market by Region
  • 6.2: Emerging Trends in the Global Nanobody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nanobody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nanobody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Sanofi
  • 7.2: Merck KGaA
  • 7.3: BIOCYTOGEN
  • 7.4: Proteintech
  • 7.5: Novartis
  • 7.6: GenScript
  • 7.7: Sensei Biotherapeutics
  • 7.8: Beroni
  • 7.9: ExeVir Bio
  • 7.10: Taisho Pharmaceutical